About 2,607 Trademarks found for “willmore f holbrow iii esq”

Filters

90240757
Dead/Abandoned

on 12 Dec 2022

AL OOTBALL ARTS PASSING PLAY RUNNING PLAY H GET IN THE GAME V IEL POSITION QUARTER TIME CLOCK ART TWO POINT CONVERSION EXTRA POINT RETURN OR TOUCHHOWN T I II III IV G 0 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 25 30 35 40 45 50 G ON SIE KICK INTERCEPTION UMBLE -5 -10

Robert Weitzman

90240757 · 07 Oct 2020

028

"OOTBALL" "ARTS" "ART" "PASSING PLAY" "INTERCEPTION" "RUNNING PLAY" "U...

77760937
Indifferent

on 19 Jun 2009

IXEMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY

Bristol-Myers Squibb Company

77760937 · 31 Dec 1969

042

Medical and scientific research, namely, conducting clinical trials an...

75017774
Dead/Cancelled

on 24 Apr 2020

CUSTOMERS & MISSION ANALYSIS PLAN/REPLAN PERFORMANCE MEASUREMENT ACTIVITY I CLARITY OF PURPOSE II PLANNING & PROBLEM AVOIDANCE III TASK ACCOMPLISHMENT IV PROVIDING FEEDBACK V EXERCISING CONTROL VI INDIVIDUAL & TEAM RELATIONSHIPS

Assessment Systems International, Inc.

75017774 · 13 Nov 1995

035

business consulting services, namely, personnel assessment and organiz...

77775355
Indifferent

on 13 Jul 2009

IXEMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY

Bristol-Myers Squibb Company

77775355 · 31 Dec 1969

042

Medical and scientific research, namely, conducting clinical trials an...

77775341
Indifferent

on 10 Jul 2009

IXAMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY

Bristol-Myers Squibb Company

77775341 · 31 Dec 1969

042

Medical and scientific research, namely, conducting clinical trials an...

77760923
Indifferent

on 19 Jun 2009

IXAMPLE A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY

Bristol-Myers Squibb Company

77760923 · 31 Dec 1969

042

Medical and scientific research, namely, conducting clinical trials an...

78699218
Indifferent

on 20 Mar 2006

BALANCE (VOL.) I, II, III, IV, V, VI, VII, VIII, IX, X, XI, XII, XIII, XIV, XV, XVI, XVII, XVIII, XIX, XX, XXI, XXII, XXIII, XXIV, XXV, XXVI, XXVII, XXVIII, XXIX, XXX, XXXI, XXXII, XXXIII, XXXIV, XXXV, XXXVI, XXXVII, XXXVIII, XXXIX, XL

Moritz, Brian D.

78699218 · 31 Dec 1969

035

BALANCE (VOL.) ONE, TWO, THREE, FOUR, FIVE, SIX, SEVEN, EIGHT, NINE, T...

77762649
Indifferent

on 24 Jun 2009

IVORY A PHASE III OPEN LABEL, RANDOMIZED, 2 ARM STUDY OF IXABEPILONE ADMINISTERED EVERY 21 DAYS VERSUS PACLITAXEL OR DOXORUBICIN ADMINISTERED EVERY 21 DAYS IN WOMEN WITH ADVANCED ENDOMETRIAL CANCER WHO HAVE PREVIOUSLY BEEN TREATED WITH CHEMOTHERAPY

Bristol-Myers Squibb Company

77762649 · 31 Dec 1969

042

Medical and scientific research, namely, conducting clinical trials an...

90104857
Live/Pending

on 21 Oct 2024

THE OCEANUS HIBERNICUS BLENDED MALT WHISK(E)Y THE DELICATE TASTE OF SCOTCH MALT WHISKY BLENDED WITH THE SWEETNESS OF IRISH MALT WHISKEY 750 ML 43% ALC/VOL HYBRIDA I. WHISKY 01A: HIGHLAND, SPEYSIDE, LOWLAND, ISLAY, SCOTLAND II. WHISKEY 02B: IRELAND III. PRODUCT OF SCOTLAND & IRELAND

HIBERNICUS LLC

90104857 · 10 Aug 2020

033

The mark consists of a design of a bottle label with a beige backgroun...

85063047
Dead/Abandoned

on 12 Aug 2013

ASIDE: A PHASE IIIB, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY STUDY TO EVALUATE THE EFFICACY AND SAFETY OF ABATACEPT ADMINISTERED SUBCUTANEOUSLY AND INTRAVENOUSLY IN SUBJECTS WITH RHEUMATOID ARTHRITIS, RECEIVING BACKGROUND METHOTREXATE, AND EXPERIENCING AN INADEQUATE RESPONSE TO METHOTREXATE

Bristol-Myers Squibb Company

85063047 · 15 Jun 2010

042

"A PHASE IIIB, MULTI-CENTER, RANDOMIZED, DOUBLE-BLIND, DOUBLE-DUMMY ST...

Country

United States

US

Status

All

Registered

Pending

Abandoned

Other

Owners

Hearst communications inc. (108)

Hearst corporation the (21)

La esquina ip llc (16)

Esquire deposition solutions llc (11)

Appclose inc. (8)

Esquire associates (7)

Id software inc. (7)

Insurance information institute inc. (7)

Bristolmyers squibb company (6)

Chang chinmei (6)

Categories

Class 9 (437)

Class 25 (274)

Class 41 (243)

Class 35 (217)

Class 42 (170)

Class 36 (136)

Class 16 (121)

Class 45 (121)

Class 28 (106)

Class 3 (93)

Class 12 (73)

Class 7 (69)

Class 33 (62)

Class 5 (59)

Class 10 (59)

Class 43 (56)

Class 11 (55)

Class 18 (44)

Class 30 (43)

Class 14 (42)

Class 20 (38)

Class 6 (35)

Class 24 (35)

Class 21 (32)

Class 32 (31)

Class 34 (31)

Class 37 (31)

Class 38 (31)

Class 39 (27)

Class 1 (26)

Class 17 (23)

Class 29 (20)

Class 19 (19)

Class 8 (18)

Class 15 (16)

Class 44 (16)

Class 4 (15)

Class 13 (15)

Class 22 (15)

Class 27 (15)

Class 40 (15)

Class 2 (11)

Class 23 (11)

Class 26 (10)

Class 31 (10)

Class 100 (4)

Attorney

Barry s agdern (48)

Maureen sheehan (34)

Bridgette fitzpatrick (24)

Tamara carmichael (15)

Robert c faber (13)

Timothy d pecsenye (11)

James s patterson (10)

Donald s holland (7)

Ariel e ronneburger (6)

Alan m harris (5)

Correspondents

Barry s agdern (51)

Maureen sheehan (28)

Bridgette fitzpatrick (23)

Robert c faber (11)

Timothy d pecsenye (10)

Donald s holland (7)

Legalforce rapc worldwide pc (7)

Hearst corporation (6)

Paul a borovay (6)

Page 260 of 261